|

The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab

RECRUITINGSponsored by Hanlim Pharm. Co., Ltd.
Actively Recruiting
SponsorHanlim Pharm. Co., Ltd.
Started2022-12-27
Est. completion2026-06
Eligibility
Age19 Years+
View on ClinicalTrials.gov →

NCT06188234

Summary

This study is to observe the prescription patterns and clinical efficacy of patients prescribed with Tenero Tab/Tenero M SR Tab for diabetes treatment in routine clinical practice.

Eligibility

Age: 19 Years+
Inclusion Criteria:

1. Adults over 19 years of age
2. Individuals diagnosed with type 2 diabetes.
3. Individuals who, at the clinical discretion, are prescribed Tenero Tab or Tenero M SR Tab for the purpose of diabetes treatment for the first time.
4. Individuals who have voluntarily provided written consent to participate in this study.

Exclusion Criteria:

1. Pregnant or breastfeeding women.
2. Individuals who are contraindicated according to the approved indications of Tenero Tab/Tenero M SR Tab.
3. Other cases where the principal investigator and study personnel deem individuals ineligible for participation in this clinical trial.

Conditions2

DiabetesDiabetes Mellitus, Type 2

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.